1-3 of 3
Idanna Innocenti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody?

Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli, Alberto Fresa, Rita Fazzi, Alessandro Sanna, Jacopo Olivieri, Ilaria Scortechini, Maria Ilaria Del Principe, Paolo Sportoletti, Idanna Innocenti, Marta Coscia, Alessandra Tedeschi, Livio Trentin, Prof., Anna Candoni, Alessandro Busca, Livio Pagano, Luca Laurenti
Journal: Blood Advances
Blood Adv bloodadvances.2024013792.
https://doi.org/10.1182/bloodadvances.2024013792
Published: 2024
Includes: Supplemental data
Journal Articles

Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort

Gianluigi Reda, Veronica Mattiello, Anna Maria Frustaci, Andrea Visentin, Francesca Romana Mauro, Idanna Innocenti, Massimo Gentile, Diana Giannarelli, Alessandro Noto, Ramona Cassin, Antonino Neri, Luca Laurenti, Alessandra Tedeschi
Journal: Blood Advances
Blood Adv (2023) 7 (4): 525–528.
https://doi.org/10.1182/bloodadvances.2022007619
Published: 2023
Includes: Supplemental data
Journal Articles

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study

Alberto Fresa, Francesco Autore, Alfonso Piciocchi, Gioacchino Catania, Andrea Visentin, Annamaria Tomasso, Marina Moretti, Candida Vitale, Annalisa Chiarenza, Francesca Morelli, Paolo Sportoletti, Roberto Marasca, Giuseppe Sapienza, Annarosa Cuccaro, Roberta Murru, Alessandro Sanna, Caterina Patti, Ilaria Angeletti, Marta Coscia, Livio Trentin, Daniela Pietrasanta, Idanna Innocenti, Luca Laurenti
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3875–3878.
https://doi.org/10.1182/bloodadvances.2022006964
Published: 2022
Includes: Supplemental data